These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 37057787)
1. THROMBOLYSIS IN PULMONARY EMBOLISM TREATMENT. Popovich YM; Rosul MV; Sich PR; Laver OP Wiad Lek; 2023; 76(3):604-609. PubMed ID: 37057787 [TBL] [Abstract][Full Text] [Related]
2. Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis. Li HY; Wang YB; Ren XY; Wang J; Wang HS; Jin YH Pharmacology; 2023; 108(2):111-126. PubMed ID: 36603558 [TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643 [TBL] [Abstract][Full Text] [Related]
4. Managing pulmonary embolism from presentation to extended treatment. Cohen AT; Dobromirski M; Gurwith MM Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642 [TBL] [Abstract][Full Text] [Related]
5. Safe-dose thrombolysis plus rivaroxaban for moderate and severe pulmonary embolism: drip, drug, and discharge. Sharifi M; Bay C; Schwartz F; Skrocki L Clin Cardiol; 2014 Feb; 37(2):78-82. PubMed ID: 24122947 [TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of a two-hour regimen of streptokinase versus alteplase in acute massive pulmonary embolism: immediate clinical and hemodynamic outcome and one-year follow-up. Meneveau N; Schiele F; Metz D; Valette B; Attali P; Vuillemenot A; Grollier G; Elaerts J; Mossard JM; Viel JF; Bassand JP J Am Coll Cardiol; 1998 Apr; 31(5):1057-63. PubMed ID: 9562007 [TBL] [Abstract][Full Text] [Related]
8. Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism. Klevanets J; Starodubtsev V; Ignatenko P; Voroshilina O; Ruzankin P; Karpenko A Ann Vasc Surg; 2017 Nov; 45():98-105. PubMed ID: 28501664 [TBL] [Abstract][Full Text] [Related]
9. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients. Meneveau N; Bassand JP; Schiele F; Bouras Y; Anguenot T; Bernard Y; Schultz R J Am Coll Cardiol; 1993 Oct; 22(4):1075-9. PubMed ID: 8409043 [TBL] [Abstract][Full Text] [Related]
10. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Marti C; John G; Konstantinides S; Combescure C; Sanchez O; Lankeit M; Meyer G; Perrier A Eur Heart J; 2015 Mar; 36(10):605-14. PubMed ID: 24917641 [TBL] [Abstract][Full Text] [Related]
11. [Anticoagulant and thrombolytic therapy in deep venous thrombosis and pulmonary embolism]. Nielsen HK; Lassen JF; Ravn HB; Husted SE Ugeskr Laeger; 1995 May; 157(20):2835-40. PubMed ID: 7785097 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis. Franco L; Giustozzi M; Agnelli G; Becattini C J Thromb Haemost; 2017 Jun; 15(6):1142-1154. PubMed ID: 28316124 [TBL] [Abstract][Full Text] [Related]
13. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Agnelli G; Becattini C; Kirschstein T Arch Intern Med; 2002 Dec 9-23; 162(22):2537-41. PubMed ID: 12456225 [TBL] [Abstract][Full Text] [Related]
14. Thrombolysis for acute intermediate-risk pulmonary embolism: A meta-analysis. Gao GY; Yang P; Liu M; Ding M; Liu GH; Tong YL; Yang CY; Meng FB Thromb Res; 2015 Nov; 136(5):932-7. PubMed ID: 26384442 [TBL] [Abstract][Full Text] [Related]